VITAMIN D DEFICIENCY [dsyn]    
HIV Infection [dsyn]    
Epidemic [phpr]    
HYPOVITAMINOSIS D [dsyn]    
Very [qlco]    
Disorder [dsyn]    
Western [spco]    
Developing Countries [qlco]    
Amount [qnco]    
Last [qlco]    
YEARS [tmco]    
VITAMIN D DEFICIENCY [dsyn]    
High Prevalence [qnco]    
HIV POSITIVE [lbtr]    
Subject [grup]    
Classic [qlco]    
Risk Factors [qnco]    
FEMALE SEX [orga]    
Low [qlco]    
Dietary intake [orgf]    
Dark skin pigmentation [fndg]    
low exposure [qlco]    
Sun [npop]    
HIV [virs]    
Related [qlco]    
Including [ftcn]    
Immune [ftcn]    
Activation [acty]    
Retroviral [virs]    
adverse effects [ftcn]    
Affect [menp]    
Status [qlco]    
Protease Inhibitors [phsu]    
Non-Nucleoside Reverse Transcriptase Inhibitors [moft]    
Low [qlco]    
Levels [qlco]    
Available [ftcn]    
Failed [ftcn]    
Associate [idcn]    
HYPOVITAMINOSIS D [dsyn]    
Specific [qlco]    
Class [inpr]    
Effects [qlco]    
Low [qlco]    
Known [qlco]    
Negative [qlco]    
IMPACT [gngm]    
BONE [bpoc]    
Health [idcn]    
Neurocognitive [inpr]    
METABOLIC [ftcn]    
Cardiovascular [bdsy]    
Immune Function [ortf]    
General Population [popg]    
Several [qnco]    
Conduct [inbe]    
HIV [virs]    
Infected [fndg]    
Subject [grup]    
HYPOVITAMINOSIS D [dsyn]    
Greater [qnco]    
Osteopenia/osteoporosis [dsyn]    
Fragility [comd]    
FRACTURES [inpo]    
VITAMIN D DEFICIENCY [dsyn]    
Independent [idcn]    
Risk Factor [qnco]    
Cardiovascular Disease [dsyn]    
METABOLIC DISORDERS [dsyn]    
INSULIN RESISTANCE [patf]    
DIABETES MELLITUS, TYPE II [dsyn]    
Last [qlco]    
EAC [neop]    
Guidelines [inpr]    
Suggest [idcn]    
screen [hlca]    
HYPOVITAMINOSIS D [dsyn]    
HIV POSITIVE [lbtr]    
Subject [grup]    
History [ocdi]    
Bone disease [dsyn]    
Chronic Kidney Disease [dsyn]    
Known [qlco]    
Risk Factors [qnco]    
VITAMIN D DEFICIENCY [dsyn]    
Recommended [idcn]    
Levels [qlco]    
Indicated [fndg]    
Values [qlco]    
OSTEOPOROSIS [dsyn]    
OSTEOMALACIA [dsyn]    
Increased [qnco]    
parathyroid hormone level [lbpr]    
Optimal [qlco]    
Maintenance dose [qnco]    
regimens [inpr]    
Established [qlco]    
IMPACT [gngm]    
Vitamin supplementation [phsu]    
PREVENT [phsu]    
Comorbidities [idcn]    
